Researchers are developing a nanopore sensing device that relies on restriction enzymes to target specific clinically relevant variants in pathogens.
Technion's Reut Shalgi is building up her lab to study how chaperones affect protein synthesis and protein folding.
The majority of the funding will be used to establish a cancer metabolomics research center on Technion's campus.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.